Medical illustration of male kidneys and bladder
HOPA News Late Breaking News

Late-Breaking HOPA News: EV-302 and CheckMate 901 Trials and Other Genitourinary Studies

In October of 2023, several practice-changing presentations about genitourinary cancers were made during the annual European Society for Medical Oncology (ESMO) Congress.

Pharmacists at work

Reflections from a Life-long Oncology Pharmacist: “Unconditional Care”

Siu Fun Wong, PharmD, FASHP, FCSHP Clinical Professor (Volunteer) Division of Hematology/Oncology, Department of Medicine UCI Health, Orange, CA

V600 Mutations
Journal Club

Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations

Detection of the BRAF V600E mutation in pediatric low-grade glioma has been associated with a lower response to standard chemotherapy.

Explore more from HOPA

-positive non-small cell lung cancer
Drug Updates

Pharmacist’s Application to Practice: Repotrectinib

Christopher L. Cornett II, PharmD PGY1 Acute Care Pharmacy Resident Anne E Hitron, PharmD, MS, MBA, BCOP ,Oncology Pharmacy Specialist, Baptist Health Louisville, Louisville, Kentucky

Metastatic Colorectal Cancer
Journal Club

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

The data from this trial confirm that FTD–TPI plus bevacizumab is an effective treatment option for patients with refractory metastatic colorectal cancer, irrespective of mutational status, which side the tumor is on, and whether patients have previously

Late Breaking News

Adapting Investigational Drug Services During a Pandemic

Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group

uveal melanoma with unresectable hepatic metastases
Drug Updates

Pharmacist’s Application to Practice: Hepzato Kit™

Lainey Vargo, PharmD, PGY2-Oncology Resident Katie Murto, PharmD, BCOP and Crystal Heise, PharmD, BCOP WVUH Hospitals, Morgantown, West Virginia.

Female reproductive organs
Late Breaking News

Late-Breaking HOPA News: RUBY5 and NRG GY018/Keynote-868 Trial

The use of molecular classification within endometrial cancer has continued to evolve with the incorporation of biomarker-driven therapy .

Myelofibrosis with anemia
Drug Updates

Pharmacist's Application to Practice: Momelotinib

Diana Mansour, PharmD, BCOP, Clinical Pharmacy Specialist, Charles M Gallagher, PharmD, PGY2 Oncology Pharmacy Resident; Kelsea Seago, PharmD, BCOP, Clinical Pharmacy Specialist, allfrom WVUH Hospitals, write about Momelotinib.

metastatic non-small cell lung cancer
Journal Club

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC

First-line treatment with osimertinib–chemotherapy led to significantly longer progression-free survival than osimertinib monotherapy among patients with EGFR-mutated advanced NSCLC.

Journal Club

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Amivantamab–chemotherapy improved PFS and intracranial PFS versus chemotherapy.